ENTITY
Bio FD&C

Bio FD&C (251120 KS)

2
Analysis
Health Care • South Korea
Bio FD&C Co Ltd researches and develops plant cell technology. The Company develops plant derived recombinant growth factors, phytopeptides, rose cell lines and other plant cell culture technologies. Bio FD&C also produces stem cell promotor, urination improver, incontinence treatment health supplement and anti-aging materials.
more
Exchange Announcement • 07 Sep 2026 13:08

Organization of Investor Relations Event

Exchange Announcement • 30 Mar 2026 13:12

Outcomes of Annual Meeting of Shareholders

Exchange Announcement • 20 Mar 2026 10:56

Submission of Audit Report

Exchange Announcement • 03 Mar 2026 14:22

Reporting reasons for holding general shareholders' meeting on the most concentrated date

Exchange Announcement • 03 Mar 2026 14:09

Resolutions for Convocation of General Meeting of Shareholders

x